INR Target Ranges for Mechanical Heart Valves
For patients with mechanical heart valves, target an INR of 2.5 (range 2.0-3.0) for bileaflet aortic valves without risk factors, and an INR of 3.0 (range 2.5-3.5) for mitral valves, tricuspid valves, aortic-mitral combinations, and any mechanical valve with additional thromboembolic risk factors. 1
Risk-Stratified Approach
Low-Risk Mechanical Aortic Valves
For current-generation bileaflet mechanical aortic valves in patients without additional risk factors:
- Target INR: 2.5 (acceptable range 2.0-3.0) 1
- This applies specifically to patients in sinus rhythm without left atrial enlargement
- Evidence shows similar thromboembolic protection but significantly lower bleeding risk compared to higher INR targets (P<0.01) 1
High-Risk Mechanical Aortic Valves
Increase the target to INR 3.0 (range 2.5-3.5) when ANY of these risk factors are present 1:
- Atrial fibrillation
- Previous thromboembolism
- Hypercoagulable state
- Older-generation prosthesis (caged-ball or caged-disc valves)
- Severe left ventricular dysfunction
Mechanical Mitral Valves
All mechanical mitral valves require INR 3.0 (range 2.5-3.5) regardless of other risk factors 1. The evidence is compelling here: the GELIA study demonstrated that lower INR ranges (2.0-3.5) were associated with worse survival compared to higher targets (2.5-4.5) in mitral valve patients 1. The thromboembolism incidence is inherently higher with mitral than aortic mechanical valves, justifying the higher anticoagulation intensity.
Multiple Valve Replacements
For aortic-mitral combinations or tricuspid valve replacements (with or without other valves):
- Target INR: 3.0 (range 2.5-3.5) 1
- Treat these as high-risk scenarios requiring more intensive anticoagulation
Older-Generation Valves
For caged-ball or tilting-disc prostheses in any position:
- Target INR: 3.0 (range 2.5-3.5) 1
- These valves have significantly higher thrombogenicity than modern bileaflet designs
Critical Implementation Points
Specify a single INR target (e.g., 2.5 or 3.0) rather than just providing a range. The acceptable therapeutic range extends 0.5 units on either side of this target 1. This approach reduces the likelihood of patients consistently hovering near the boundaries where risk increases, and INR fluctuations themselves are associated with increased complications 1.
Common Pitfall: Aspirin Addition
The 2020 ACC/AHA guidelines provide nuanced recommendations on aspirin 1:
- Do NOT routinely add aspirin to warfarin for mechanical valves
- Consider adding low-dose aspirin (75-100 mg daily) only if thromboembolism occurs despite adequate INR (Class IIa recommendation)
- May consider aspirin addition for concomitant atherosclerotic disease (Class IIb recommendation)
- Be aware that aspirin increases bleeding risk, particularly when INR exceeds 3.0
Monitoring Considerations
Patients achieve therapeutic range more consistently with lower INR targets: 74.5% time-in-range for INR 2.0-3.5 versus only 44.5% for INR 3.0-4.5 1. This practical consideration supports the moderate-intensity approach for appropriate patients.
What NOT to Use
Direct oral anticoagulants (DOACs) are contraindicated for mechanical heart valves 1. Only vitamin K antagonists (warfarin) provide proven protection against valve thrombosis (OR: 0.11 for valve thrombosis; OR: 0.21 for thromboembolic events) 1.